FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W168796211> ?p ?o ?g. }

• W168796211 endingPage "34" @default.
• W168796211 startingPage "29" @default.
• W168796211 abstract "Back to table of contents Previous article Next article No AccessAntidepressant effects of carbamazepinePublished Online:1 Apr 2006https://doi.org/10.1176/ajp.143.1.29AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractThirty-five depressed patients diagnosed by DSM-III criteria participated in a double-blind study of the acute antidepressant effects of the anticonvulsant carbamazepine, at average doses of 971 mg/day, achieving mean +/- SD blood levels of 9.3 +/- 1.9 micrograms/ml (range, 3-12.5 micrograms/ml). Twenty patients (57%) showed at least mild improvement, and 12 showed more substantial improvement. Possible clinical predictors of antidepressant response to carbamazepine are discussed. These preliminary data suggest that carbamazepine has some acute antidepressant efficacy in addition to the growing evidence that it has acute antimanic and longer-term prophylactic efficacy in both phases of manic-depressive illness. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byMingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats5 October 2022 | Frontiers in Pharmacology, Vol. 13Insights into the wavelength-dependent photolysis of chlorite: Elimination of carbamazepine and formation of chlorateChemosphere, Vol. 288Peripheral Nerve Interface Applications, Vagal Nerve Stimulation12 June 2022Einsatz von Antipsychotika, Antikonvulsiva, Stimulantien, Benzodiazepinen und Hypnotika bei therapieresistenten Depressionen1 March 2023Naloxone-reversible antidepressant-like effect of carbamazepine in mice: Without tolerance and withdrawal syndromeNeuroscience Letters, Vol. 765Pharmacological evaluation of NO/cGMP/KATP channels pathway in the antidepressant-like effect of carbamazepine in mice7 December 2020 | Behavioural Pharmacology, Vol. 32, No. 1Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment9 November 2020 | Psychotherapy and Psychosomatics, Vol. 90, No. 3Carbamazepine –An oldie but a goodie–A clinician’s perspectiveSeizure, Vol. 83Carbamazepine: Out with the old, in with the new?Seizure, Vol. 83Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysisJournal of Affective Disorders, Vol. 269Peripheral Nerve Interface Applications, Vagal Nerve Stimulation17 August 2020 Long-Term Beneficial Effects of Acupuncture with Reduced Risk of Depression Development Following Trigeminal Neuralgia: A Nationwide Population-Based Cohort Study 1 December 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16Bipolar Disorders, Vol. 21, No. 5Pharmaceuticals, Vol. 12, No. 2Psiquiatría Biológica, Vol. 24, No. 1The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm5 November 2016 | International Journal of Neuropsychopharmacology, Vol. 55The Role of Antiepileptic Drugs in Bipolar Depression18 November 2016Expert Review of Neurotherapeutics, Vol. 14, No. 6L'Encéphale, Vol. 39Neuroscience & Biobehavioral Reviews, Vol. 37, No. 10International Journal of Neuropsychopharmacology, Vol. 16, No. 2Mood disorders2 July 2013, Vol. 108Lithium et anticonvulsivants dans la dépression bipolaireL'Encéphale, Vol. 37Pharmacological Treatment of Bipolar Depression13 August 2010Pharmacological treatment of bipolar depressionAdvances in Psychiatric Treatment, Vol. 16, No. 5The Psychopharmacology Algorithm Project at the Harvard South Shore ProgramHarvard Review of Psychiatry, Vol. 18, No. 1Anticonvulsants in the Treatment of Major Depressive DisorderHarvard Review of Psychiatry, Vol. 17, No. 4Human Psychopharmacology: Clinical and Experimental, Vol. 24, No. 1, Vol. 42The World Journal of Biological Psychiatry, Vol. 10, No. 4-2British Journal of Clinical Pharmacology, Vol. 67, No. 2Journal of the British Institute of Mental Handicap (APEX), Vol. 21, No. 3Drugs, Vol. 69, No. 15Treatment of bipolar depression: An updateJournal of Affective Disorders, Vol. 109, No. 1-2Bipolar depression: trial-based insights to guide patient care1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 10, No. 2The effectiveness of anticonvulsants in psychiatric disorders1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 10, No. 1Pharmacological therapyJournal of Affective Disorders, Vol. 109, No. 1-2Journal of Psychiatric Research, Vol. 41, No. 3-4Neuroscience & Biobehavioral Reviews, Vol. 31, No. 6Psychoneuroendocrinology, Vol. 32, No. 6The International Journal of Neuropsychopharmacology, Vol. 10, No. 05Progress in Neurotherapeutics and Neuropsychopharmacology, Vol. 2, No. 1Annals of General Psychiatry, Vol. 6, No. 1Expert Opinion on Pharmacotherapy, Vol. 8, No. 1CNS Drugs, Vol. 21, No. 1European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, No. 1CNS Spectrums, Vol. 11, No. 10CNS Drugs, Vol. 20, No. 3L'Encéphale, Vol. 31, No. 5Psychiatric Clinics of North America, Vol. 28, No. 2Psychiatric Clinics of North America, Vol. 28, No. 2Bipolar Disorders, Vol. 7Advances in Psychiatric Treatment, Vol. 11, No. 1Expert Opinion on Pharmacotherapy, Vol. 6, No. 16Expert Opinion on Pharmacotherapy, Vol. 6, No. 4Expert Review of Neurotherapeutics, Vol. 5, No. 1Therapy, Vol. 2, No. 4Australian and New Zealand Clinical Practice Guidelines for the Treatment of Bipolar Disorder26 June 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 38, No. 5Clinical Neuroscience Research, Vol. 4, No. 1-2International Clinical Psychopharmacology, Vol. 19, No. 3Australian and New Zealand Journal of Psychiatry, Vol. 38, No. 5Current Status of the Utilization of Antiepileptic Treatments in Mood, Anxiety and Aggression: Drugs and Devices25 June 2016 | Clinical EEG and Neuroscience, Vol. 35, No. 1Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark15 September 2003 | Acta Psychiatrica Scandinavica, Vol. 108Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approachPsychiatric Clinics of North America, Vol. 26, No. 2Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options7 April 2003 | Bipolar Disorders, Vol. 5, No. 2Neurobiologia do transtorno de humor bipolar e tomada de decisão na abordagem psicofarmacológicaRevista de Psiquiatria do Rio Grande do Sul, Vol. 25, No. suppl 1Journal of Affective Disorders, Vol. 73, No. 1-2CNS Spectrums, Vol. 8, No. 12Journal of Clinical Psychopharmacology, Vol. 23, No. 2CNS Drugs, Vol. 17, No. 1Gabapentin augmentation therapy in bipolar depression25 September 2002 | Bipolar Disorders, Vol. 4, No. 5Carbamazepine-Provoked Hepatotoxicity and Possible Aetiopathological Role of Glutathione in the Events15 August 2012 | Adverse Drug Reactions and Toxicological Reviews, Vol. 21, No. 3The Expanding Pharmacopoeia for Bipolar DisorderAnnual Review of Medicine, Vol. 53, No. 1Biological Psychiatry, Vol. 51, No. 3Journal of Affective Disorders, Vol. 72Clinical Neuroscience Research, Vol. 2, No. 3-4Clinical Neuroscience Research, Vol. 2, No. 3-4Experimental and Clinical Psychopharmacology, Vol. 10, No. 3What makes a drug a primary mood stabilizer?18 March 2002 | Molecular Psychiatry, Vol. 7, No. S1Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men18 July 2008 | Acta Psychiatrica Scandinavica, Vol. 104, No. 5Medical Clinics of North America, Vol. 85, No. 3Journal of Affective Disorders, Vol. 64, No. 1Expert Opinion on Pharmacotherapy, Vol. 2, No. 10Pharmacotherapy, Vol. 21, No. 7Journal of Affective Disorders, Vol. 59Journal of Affective Disorders, Vol. 59Pharmacotherapy, Vol. 20, No. 12The World Journal of Biological Psychiatry, Vol. 1, No. 3Algorithms for the Pharmacotherapy of Acute Depression in Patients With Bipolar DisorderPsychiatric Annals, Vol. 29, No. 5Biological Psychiatry, Vol. 46, No. 2European Neuropsychopharmacology, Vol. 9Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 22, No. 1CNS Spectrums, Vol. 3, No. 5The Clinical Journal of Pain, Vol. 14, No. 1Recent Advances in the Pharmacologic Treatment of Bipolar IllnessPsychiatric Annals, Vol. 27, No. 7Epilepsy Research, Vol. 25, No. 2Journal of Clinical Psychopharmacology, Vol. 16, No. SUPPLEMENT 1British Journal of Psychiatry, Vol. 168, No. 3Treatment of Acute Bipolar Depression: A Review of the Literature1 November 1995 | The Canadian Journal of Psychiatry, Vol. 40, No. 9Brain Research Reviews, Vol. 20, No. 3Journal of Clinical Psychopharmacology, Vol. 15, No. 5Psychiatric Bulletin, Vol. 19, No. 11Depression, Vol. 2, No. 3European Archives of Psychiatry and Clinical Neuroscience, Vol. 243, No. 5Psychiatry Research, Vol. 51, No. 2European Neuropsychopharmacology, Vol. 4, No. 4Medicinal Research Reviews, Vol. 13, No. 3European Journal of Pharmacology, Vol. 236, No. 1Pharmacology Biochemistry and Behavior, Vol. 45, No. 2Psychiatry Research, Vol. 49, No. 3Epilepsy Research, Vol. 16, No. 1Psychiatric Clinics of North America, Vol. 16, No. 3Irish Journal of Psychological Medicine, Vol. 10, No. 2Acta Neuropsychiatrica, Vol. 5, No. 3Mixed neurologic and psychiatric disorders: Pharmacological issuesComprehensive Psychiatry, Vol. 33, No. 5The management of treatment-resistant affective disorder: clinical perspectives1 July 2016 | Journal of Psychopharmacology, Vol. 6, No. 2Synapse, Vol. 10, No. 2Der Schmerz, Vol. 6, No. 1Biological Psychiatry, Vol. 32, No. 4Biological Psychiatry, Vol. 31, No. 5Pharmacology & Toxicology, Vol. 71Psychoendocrinological Aspects of Affective DisordersThe Journal of General Psychology, Vol. 118, No. 4Biological Psychiatry, Vol. 29, No. 8European Journal of Pharmacology, Vol. 193, No. 2International Review of Psychiatry, Vol. 3, No. 1Psychiatric Uses of Anticonvulsants29 June 2016 | Journal of Pharmacy Practice, Vol. 3, No. 4Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 5Addition of lithium carbonate to carbamazepine: hematological and thyroid effects1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 5Is the carbamazepine-phenelzine combination safe?1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 3Affective disorder following use of phenylpropanolamine1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 3Pharmacological Research, Vol. 22Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 29, No. 3British Journal of Psychiatry, Vol. 157, No. 3Pharmacological Management of Refractory Depression1 June 1989 | The Canadian Journal of Psychiatry, Vol. 34, No. 5Pharmacotherapy of the Borderline Patient: A Critical Review and Clinical Guidelines1 May 1989 | The Canadian Journal of Psychiatry, Vol. 34, No. 4Psychological Medicine, Vol. 19, No. 3Hyponatrémie induite par la carbamazépine et affection rénale: à propos d’un cas28 April 2020 | Psychiatry and Psychobiology, Vol. 4, No. 4A carbamazepine trial in chronic, treatment-refractory schizophrenia1 April 2006 | American Journal of Psychiatry, Vol. 145, No. 6Pharmacoepidemiology Methods for Identifying and Quantifying Behavioral Effects of Neuropharmacological Agents30 May 2017 | Drug Intelligence & Clinical Pharmacy, Vol. 22, No. 3Neuropharmacology, Vol. 27, No. 2Epilepsia, Vol. 29, No. 2The Pharmacological Treatment of Tricyclic-Resistant Depression: Review and Management Guidelines26 June 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 21, No. 4Treatment-Resistant DepressionPsychiatric Annals, Vol. 17, No. 4Dr. Klein and Associates ReplyEHUD KLEIN, THOMAS W. UHDE, and ROBERT M. POST1 April 2006 | American Journal of Psychiatry, Vol. 144, No. 2Psychopharmacology, Vol. 92, No. 3Biological Psychiatry, Vol. 22, No. 8Biological Psychiatry, Vol. 22, No. 9Psychiatry Research, Vol. 22, No. 1Psychiatry Research, Vol. 21, No. 1Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 26, No. 4 Volume 143Issue 1 January 1986Pages 29-34 Metrics PDF download History Published online 1 April 2006 Published in print 1 January 1986" @default.
• W168796211 created "2016-06-24" @default.
• W168796211 date "1986-01-01" @default.
• W168796211 modified "2023-10-18" @default.
• W168796211 title "Antidepressant effects of carbamazepine" @default.
• W168796211 cites W147127941 @default.
• W168796211 cites W169914358 @default.
• W168796211 cites W1890987751 @default.
• W168796211 cites W1968350586 @default.
• W168796211 cites W1986803960 @default.
• W168796211 cites W1996389295 @default.
• W168796211 cites W2000229881 @default.
• W168796211 cites W2001695803 @default.
• W168796211 cites W2002235845 @default.
• W168796211 cites W2011632772 @default.
• W168796211 cites W2024700133 @default.
• W168796211 cites W2033795693 @default.
• W168796211 cites W2064793387 @default.
• W168796211 cites W2068216984 @default.
• W168796211 cites W2069959657 @default.
• W168796211 cites W2075105194 @default.
• W168796211 cites W2087444783 @default.
• W168796211 cites W2093495407 @default.
• W168796211 cites W2109973761 @default.
• W168796211 cites W2114613490 @default.
• W168796211 cites W2115147704 @default.
• W168796211 cites W2152227839 @default.
• W168796211 cites W2167464586 @default.
• W168796211 cites W2271276387 @default.
• W168796211 cites W2395092195 @default.
• W168796211 cites W2410574118 @default.
• W168796211 cites W2418223479 @default.
• W168796211 cites W2426511475 @default.
• W168796211 cites W306921096 @default.
• W168796211 cites W1986947347 @default.
• W168796211 doi "https://doi.org/10.1176/ajp.143.1.29" @default.
• W168796211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3510572" @default.
• W168796211 hasPublicationYear "1986" @default.
• W168796211 type Work @default.
• W168796211 sameAs 168796211 @default.
• W168796211 citedByCount "205" @default.
• W168796211 countsByYear W1687962112012 @default.
• W168796211 countsByYear W1687962112013 @default.
• W168796211 countsByYear W1687962112014 @default.
• W168796211 countsByYear W1687962112016 @default.
• W168796211 countsByYear W1687962112017 @default.
• W168796211 countsByYear W1687962112019 @default.
• W168796211 countsByYear W1687962112020 @default.
• W168796211 countsByYear W1687962112021 @default.
• W168796211 countsByYear W1687962112022 @default.
• W168796211 countsByYear W1687962112023 @default.
• W168796211 crossrefType "journal-article" @default.
• W168796211 hasConcept C118552586 @default.
• W168796211 hasConcept C2775858608 @default.
• W168796211 hasConcept C2778186239 @default.
• W168796211 hasConcept C2779177272 @default.
• W168796211 hasConcept C2779253243 @default.
• W168796211 hasConcept C558461103 @default.
• W168796211 hasConcept C71924100 @default.
• W168796211 hasConcept C98274493 @default.
• W168796211 hasConceptScore W168796211C118552586 @default.
• W168796211 hasConceptScore W168796211C2775858608 @default.
• W168796211 hasConceptScore W168796211C2778186239 @default.
• W168796211 hasConceptScore W168796211C2779177272 @default.
• W168796211 hasConceptScore W168796211C2779253243 @default.
• W168796211 hasConceptScore W168796211C558461103 @default.
• W168796211 hasConceptScore W168796211C71924100 @default.
• W168796211 hasConceptScore W168796211C98274493 @default.
• W168796211 hasIssue "1" @default.
• W168796211 hasLocation W1687962111 @default.
• W168796211 hasLocation W1687962112 @default.
• W168796211 hasOpenAccess W168796211 @default.
• W168796211 hasPrimaryLocation W1687962111 @default.
• W168796211 hasRelatedWork W1969760382 @default.
• W168796211 hasRelatedWork W2059463201 @default.
• W168796211 hasRelatedWork W2066519361 @default.
• W168796211 hasRelatedWork W2072053288 @default.
• W168796211 hasRelatedWork W2153335219 @default.
• W168796211 hasRelatedWork W2397731726 @default.
• W168796211 hasRelatedWork W2429723649 @default.
• W168796211 hasRelatedWork W2906906539 @default.
• W168796211 hasRelatedWork W3135689680 @default.
• W168796211 hasRelatedWork W4200541214 @default.
• W168796211 hasVolume "143" @default.
• W168796211 isParatext "false" @default.
• W168796211 isRetracted "false" @default.
• W168796211 magId "168796211" @default.
• W168796211 workType "article" @default.